Patient data and summary of tumorVH gene sequences
Patient . | Sex . | Age . | WBC × 10−9/L . | sIg . | VH GL donor . | Homology (%) . | Intraclonal variation . |
---|---|---|---|---|---|---|---|
1 | F | 73 | 8.4 | MDκ | V3-21 | 99.6 (B/S) | No |
2 | F | 65 | 14.5 | λ | V1-1 | 99.0 (B/S) | No |
3 | F | 54 | 7.4 | MDκ | V1-2 | 97.3* (B/S) | Yes |
4 | F | 68 | 12.4 | MDκ | V3-33 | 100 (B/S) | No |
97.6* (CW) | Yes |
Patient . | Sex . | Age . | WBC × 10−9/L . | sIg . | VH GL donor . | Homology (%) . | Intraclonal variation . |
---|---|---|---|---|---|---|---|
1 | F | 73 | 8.4 | MDκ | V3-21 | 99.6 (B/S) | No |
2 | F | 65 | 14.5 | λ | V1-1 | 99.0 (B/S) | No |
3 | F | 54 | 7.4 | MDκ | V1-2 | 97.3* (B/S) | Yes |
4 | F | 68 | 12.4 | MDκ | V3-33 | 100 (B/S) | No |
97.6* (CW) | Yes |